The major constant product of the enzymatic activity of PSMA is glutamate, which was shown to be present in excess amount in prostate carcinoma, even more so in African-American patients when compared to Caucasian-American research subjects, and to favor higher growth rates and aggressive behavior in human prostate carcinoma cell lines [21]. Here, FOLH1 is linked to prostate carcinoma.